Clinical Trial Update: An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial of Vagitocin for vaginal atrophy in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• Vagitocin

Snippet

Sponsor: PepTonic Medical AB | Conditions: Atrophy | Phase 2 | Status: COMPLETED